Share

ENDO 2023: Better Than Ever

Aug 2023 cover The Endocrine Society returns to Chicago for its first all in-person meeting since 2019. Scientists and clinicians descended upon the Windy City in droves from near and far to take part in the biggest endocrinology meeting in the world. From the latest research to the newest patient therapies to networking with colleagues. or simply hugging...
Share

The Devil Is in the [Vitamin] D-etails

Each year, the hottest tickets at ENDO are the various debates and ENDO 2023 was no exception when experts weighed in on the pros and cons of using vitamin D supplements in female patients at risk for osteoporotic fracture. One ENDO 2023 session that proved popular in June was “Is there a role for vitamin...
Share

Breaking Barriers in Bone Health

With the recent reexamination of how to consider race/ethnicity in medical treatment, many practitioners may feel confused about implementing such procedures. The ENDO 2023 symposium “Addressing Racial and Ethnic Disparities in Osteoporosis Care” provided attendees with an understanding of the impact of incorporating race/ethnicity in osteoporosis care as well as suggestions for treating their own...
Share

Topline Results Announced from Trial of Non-Pharmacological Treatment for Osteopenia

Bone Health Technologies (BHT) announced yesterday topline results of its pivotal trial of the Osteoboost Vibration Belt. The results found that using Osteoboost more than three times per week in each of four quarters provided a statistically significant reduction in the loss of vertebral bone strength among participants— with no reported device-related serious adverse events....